The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English (UK)
Deutsch
English (UK)
Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis
NIL
Jahr
Publikationsjahr
2023
Autoren
Autorenliste der Publikation
Sotirchos ES, Hu C, Smith MD, Lord HN, DuVal AL, Arrambide G, Montalban X, Akgün K, Ziemssen T, Naismith RT, Hersh CM, Hyland M, Krupp LB, Nicholas JA, Bermel RA, Mowry EM, Calabresi PA, Fitzgerald KC.
Verlag
Publisher-Information
Neurology. 2023 Oct 10:10.1212/WNL.0000000000207957.
Link
Zur Publikation (externer Server)
https://doi.org/10.1212/wnl.0000000000207957
Tags
Forschungsthemen
Multiple Sklerose
Neuroimmunologie
MSZ
NIL
2023
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab
MS Treatments
Jahr
2024
Sensitive Identification of Asymmetries and Neuromuscular Deficits in Lower Limb Function in Early Multiple Sclerosis
Mobility
Jahr
2024
Neurofilaments as biomarkers in neurological disorders — towards clinical application
NIL
Jahr
2024
Use of machine learning algorithms to detect fear of falling in people with multiple sclerosis
Mobility
Jahr
2024
Consensus quality indicators for monitoring multiple sclerosis
MASC
Jahr
2024